Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Chih-Hui Lin | Chairman, GM, Managerial Officer & President | 4.71M | -- | 1983 |
Mr. Hong-Qin Bai | Senior VP & Finance Officer | 3.5M | -- | -- |
Ms. Jia-Xin Zhang | Senior Vice President | 3.02M | -- | -- |
Mr. Sheng-Ren Yang | Senior Vice President | 3.14M | -- | -- |
Liyu Huang | Chief Financial Officer | -- | -- | -- |
Jinghua Cao | Accounting Supervisor | -- | -- | -- |
Mr. Zen Young | Vice President of Sales - HP, Marketing & Medical | -- | -- | -- |
Synmosa Biopharma Corporation
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 9, 2024 at 12:00 AM UTC
Ex-Dividend Date